PortfoliosLab logo
AnteoTech Limited (ADO.AX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

AU000000ADO8

Highlights

Market Cap

A$21.64M

Total Revenue (TTM)

-A$342.80K

Gross Profit (TTM)

-A$342.80K

EBITDA (TTM)

-A$9.14M

Year Range

A$0.01 - A$0.04

Target Price

A$0.38

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

Returns By Period

AnteoTech Limited (ADO.AX) returned -52.94% year-to-date (YTD) and -65.22% over the past 12 months. Over the past 10 years, ADO.AX returned -19.90% annually, underperforming the S&P 500 benchmark at 10.62%.


ADO.AX

YTD

-52.94%

1M

-27.27%

6M

-70.15%

1Y

-65.22%

5Y*

-18.28%

10Y*

-19.90%

^GSPC (Benchmark)

YTD

-1.31%

1M

8.23%

6M

-3.18%

1Y

11.14%

5Y*

15.18%

10Y*

10.62%

*Annualized

Monthly Returns

The table below presents the monthly returns of ADO.AX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-0.00%-11.76%-20.00%-41.67%14.29%-52.94%
2024-11.11%-9.38%27.59%-43.24%14.29%-16.67%-0.00%10.00%-4.55%23.81%-30.77%-5.56%-52.78%
2023-12.28%-0.00%-22.00%-15.38%30.30%-6.98%-27.50%3.45%-13.33%3.85%18.52%12.50%-36.84%
2022-36.07%-5.13%-40.54%4.55%-8.70%-38.10%7.69%-10.00%-25.40%17.02%-3.64%7.55%-81.31%
2021-4.76%135.00%6.38%74.00%-26.44%-20.31%-11.76%-28.89%65.62%-15.09%-13.33%56.41%190.48%
202027.44%-10.58%-34.69%43.75%4.35%-16.67%125.00%22.22%45.45%43.75%-13.04%5.00%388.37%
2019-0.00%11.95%-10.67%5.66%-24.40%-0.00%-0.00%0.00%7.87%-7.30%38.58%22.16%35.22%
201812.00%-22.02%14.50%-12.67%-14.50%25.00%13.57%-17.61%-14.50%16.96%28.24%-5.36%6.00%
2017-4.95%-2.47%-13.20%2.91%-20.44%-40.71%18.67%-5.62%-22.02%14.50%-18.67%22.95%-60.94%
2016-13.43%-12.65%-16.03%13.35%-27.17%-6.97%-0.00%50.00%-16.58%7.91%-12.87%-12.73%-49.93%
2015-20.05%-1.01%-1.02%1.03%-12.61%-5.98%47.30%-16.53%-2.02%-6.43%-11.29%6.09%-31.03%
2014-0.00%0.00%53.17%-16.34%12.22%-17.41%-23.69%0.00%0.00%-3.43%-17.89%4.41%-24.97%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ADO.AX is 11, meaning it’s performing worse than 89% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of ADO.AX is 1111
Overall Rank
The Sharpe Ratio Rank of ADO.AX is 1515
Sharpe Ratio Rank
The Sortino Ratio Rank of ADO.AX is 1515
Sortino Ratio Rank
The Omega Ratio Rank of ADO.AX is 1616
Omega Ratio Rank
The Calmar Ratio Rank of ADO.AX is 99
Calmar Ratio Rank
The Martin Ratio Rank of ADO.AX is 11
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for AnteoTech Limited (ADO.AX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

AnteoTech Limited Sharpe ratios as of May 12, 2025 (values are recalculated daily):

  • 1-Year: -0.67
  • 5-Year: -0.16
  • 10-Year: -0.17
  • All Time: -0.06

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of AnteoTech Limited compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend History


AnteoTech Limited doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the AnteoTech Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the AnteoTech Limited was 99.93%, occurring on Feb 24, 2009. The portfolio has not yet recovered.

The current AnteoTech Limited drawdown is 99.86%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.93%Jul 23, 20011948Feb 24, 2009
-51.07%Apr 10, 200033May 24, 200090Sep 27, 2000123
-45.51%Feb 5, 200189Jun 7, 200131Jul 20, 2001120
-25.97%Nov 27, 200019Dec 21, 200031Feb 2, 200150
-14.55%Oct 2, 200011Oct 16, 200024Nov 17, 200035

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of AnteoTech Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of AnteoTech Limited, comparing actual results with analytics estimates.


Actual
Estimate

Valuation

The Valuation section provides an overview of how AnteoTech Limited is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for ADO.AX compared to other companies in the Biotechnology industry. ADO.AX currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ADO.AX relative to other companies in the Biotechnology industry. Currently, ADO.AX has a P/S ratio of 82.3. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ADO.AX in comparison with other companies in the Biotechnology industry. Currently, ADO.AX has a P/B value of 2.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items